Natuzzi (NYSE:NTZ) reported quarterly losses of €(0.02) per share. This is a 100 percent decrease over losses of €(0.01) per share from the same period last year. The company reported €116.90 million in sales this quarter. This is a 10.48 percent decrease over sales of €130.58 million the same period last year.
Related Posts
Statera Biopharma Late Thursday Reported It Completed Fiscal 2021 Audit; Files Form 10-K
FORT COLLINS, CO / ACCESSWIRE / October 6, 2022 / Statera Biopharma, Inc.
MEI Pharma Announces Planned Departure Of Chief Financial Officer Brian Drazba And Appointment Of Justin File As Successor
MEI Pharma, Inc. (NASDAQ:MEIP) (the "Company"), a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that, consistent with the Company's succession planning, Brian
Disney, Expeditors International And 3 Stocks To Watch Heading Into Tuesday
With US stock futures trading slightly lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: